Evidence map›Paper›PMID 42745508›Full record

ArticleJournal of immunology research2026

Impact of Transport Media on IL-33 Levels in Samples From Patients With Viral Respiratory Infections.

Daniela Moreno-Tapia, Yaneisi Vázquez, Valentina Pavez, Omar P Vallejos, José Acevedo-López, Camila Pardo, Felipe A Cancino, Ana María Contreras, Marcela Ferrés, Dona Benadof and 13 more

Abstract read
In one paragraph

Article in Journal of immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Daniela Moreno-TapiaMillennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile, imii.cl.
Yaneisi VázquezMillennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile, imii.cl.
Valentina PavezMillennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile, imii.cl.ORCID https://orcid.org/0009-0002-3651-564X
Omar P VallejosMillennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile, imii.cl.ORCID https://orcid.org/0000-0002-5203-7062
José Acevedo-LópezMillennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile, imii.cl.
Camila PardoMillennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile, imii.cl.
Felipe A CancinoMillennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile, imii.cl.ORCID https://orcid.org/0000-0002-8287-171X
Ana María ContrerasLaboratorio de Infectología y Virología Molecular, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile, uc.cl.
Marcela FerrésLaboratorio de Infectología y Virología Molecular, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile, uc.cl.
Dona BenadofLaboratorio Clínico y Microbiología Hospital Roberto del Río, Santiago, Chile.
Ana María GuzmánLaboratorio Hospital Clínico UC, Departamento de Laboratorios Clínicos, Facultad de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile, uc.cl.
Francisca ValdiviesoLaboratorio de Microbiología, Hospital Luis Calvo Mackenna, Santiago, Chile.
Mauricio FarfánLaboratorio de Microbiología, Hospital Luis Calvo Mackenna, Santiago, Chile.
María Luisa RiosecoFacultad de Medicina, Universidad San Sebastián, Sede Patagonia, Puerto Montt, Región de Los Lagos, Chile, uss.cl.
Valentina GutiérrezDepartamento de Enfermedades Infecciosas e Inmunología Pediátricas, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile, uc.cl.ORCID https://orcid.org/0000-0002-5815-5035
Pablo J BertrandDivisión de Pediatría, Facultad de Medicina, Departamento de Enfermedades Respiratorias Pediátricas, Pontificia Universidad Católica de Chile, Santiago, Chile, uc.cl.ORCID https://orcid.org/0000-0002-7736-0296
Eduardo EspejoLaboratorio Clínico, Hospital Dr. Sótero del Río, Santiago, Chile.ORCID https://orcid.org/0009-0004-9663-3423
Angélica DomínguezSchool of Public Health, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile, uc.cl.ORCID https://orcid.org/0000-0001-7477-7574
Cecilia V TapiaLaboratorio Clínico Hospital de Carabineros, Santiago, Chile.
Pablo A GonzálezMillennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile, imii.cl.ORCID https://orcid.org/0000-0001-7709-6870
Hernán F PeñalozaMillennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile, imii.cl.ORCID https://orcid.org/0000-0002-1593-678X
Alexis M KalergisMillennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile, imii.cl.
Susan M BuenoMillennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile, imii.cl.ORCID https://orcid.org/0000-0002-7551-8088

Funding

ANID-ICM Millennium Institute on Immunology and Immunotherapy ICN2021_045ANID IDeA I+D Tecnologías Avanzadas Program (Concurso IDeA I+D Tecnologías Avanzadas 2025) TA25I10042CORFO program of Chilean Ministry of Economy 13CTI-21526-P5CORFO program of Chilean Ministry of Economy 23CTEC-250091-P2INNOVA-CORFO program of the Chilean Ministry of Economy 11IDL2-10668INNOVA-CORFO program of the Chilean Ministry of Economy 15VEIID-45704
6 · The paper itself

Abstract

Interleukin-33 (IL-33) is an IL-1 family cytokine that activates various immune cells and induces both systemic and localized Th2 responses during infection. An association between IL-33 and its suppresion of tumorigenicity 2 (ST2) receptor with inflammation during respiratory tract infection has been previously reported. Furthermore, some data suggest that during respiratory infections, IL-33 may serve as an indicator of disease severity, as high levels of this cytokine have been found in nasopharyngeal swab (NPS) samples of infants with lower respiratory tract disease caused by respiratory syncytial virus (RSV). As viral diagnosis is mostly compartmentalized in NPS, in this report, we aimed at detecting IL-33 in NPS from patients with respiratory tract infections that were collected in two different transport media (universal transport medium [UTM], and phosphate-buffered saline [PBS]). IL-33 levels were evaluated in 230 NPS samples, 121 obtained in PBS, and 109 in UTM. The samples were tested for RSV, metapneumovirus, adenovirus (ADV), influenza, and parainfluenza. In this cohort, higher levels of IL-33 were detected in virus-positive samples collected in PBS compared to virus-negative samples collected in the same transport medium. In addition, RSV- and FLU-positive samples collected in PBS showed higher measured IL-33 levels than those collected in UTM. No significant differences were found for the other viruses included in this study. These findings highlight the importance of considering sample collection and transport conditions when interpreting IL-33 measurements in NPS, particularly in future studies evaluating IL-33 as a potential severity-associated biomarker during RSV or influenza infection.

Indexed as

Culture MediaInterleukin-33Respiratory Tract InfectionsVirus DiseasesChild, PreschoolFemaleHumansInfantMaleNasopharynxCulture MediaIL33 protein, humanInterleukin-33IL-33 detectionNPSPBSrespiratory tract infectionUTM

Identifiers

PMID42745508
PMCPMC13579107

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.